Conference
P4.9 A phase 2, randomized, placebo-controlled, multiple ascending-dose study of ACE-031 (ActRIIB-IgG1) in Duchenne muscular dystrophy (DMD): Preliminary results
Authors
Campbell C; Attie KM; Mah JK; Tarnopolsky M; Selby K; McMillan HJ; Yang Y; Wilson D; Barger R; Sherman ML
Volume
21
Publisher
Elsevier
Publication Date
October 2011
DOI
10.1016/j.nmd.2011.06.974
Conference proceedings
Neuromuscular Disorders
Issue
9-10
ISSN
0960-8966